HK1224215A1 - Use of high dose pridopidine for treating huntingtons disease - Google Patents

Use of high dose pridopidine for treating huntingtons disease

Info

Publication number
HK1224215A1
HK1224215A1 HK16112619.8A HK16112619A HK1224215A1 HK 1224215 A1 HK1224215 A1 HK 1224215A1 HK 16112619 A HK16112619 A HK 16112619A HK 1224215 A1 HK1224215 A1 HK 1224215A1
Authority
HK
Hong Kong
Prior art keywords
treating
high dose
huntingtons disease
dose pridopidine
pridopidine
Prior art date
Application number
HK16112619.8A
Other languages
Chinese (zh)
Inventor
Bassan Merav
Eyal Eli
Lukasiewicz Hagai Esther
Kristina Sveinsdotter Teige Wickenberg Anna
Original Assignee
Teva Pharmaceuticals Int Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Teva Pharmaceuticals Int Gmbh filed Critical Teva Pharmaceuticals Int Gmbh
Publication of HK1224215A1 publication Critical patent/HK1224215A1/en

Links

HK16112619.8A 2013-06-21 2016-11-02 Use of high dose pridopidine for treating huntingtons disease HK1224215A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201361837928P 2013-06-21 2013-06-21
US201361877832P 2013-09-13 2013-09-13
IS2014043204 2014-06-19

Publications (1)

Publication Number Publication Date
HK1224215A1 true HK1224215A1 (en) 2017-08-18

Family

ID=59626734

Family Applications (1)

Application Number Title Priority Date Filing Date
HK16112619.8A HK1224215A1 (en) 2013-06-21 2016-11-02 Use of high dose pridopidine for treating huntingtons disease

Country Status (1)

Country Link
HK (1) HK1224215A1 (en)

Similar Documents

Publication Publication Date Title
HK1221646A1 (en) Use of high dose pridopidine for treating huntingtons disease
IL243976A0 (en) Kdm1a inhibitors for the treatment of disease
HK1225305A1 (en) Methods and compositions for treating brain diseases
IL241232A0 (en) Compounds for treatment of cancer
EP2968348A4 (en) Compounds for treatment of cancer
EP3019491A4 (en) Kinase inhibitors for the treatment of disease
HK1220324A1 (en) Methods, compounds, and compositions for the treatment of angiotensin-related diseases
EP2958936A4 (en) Methods and compositions for treatment of forbes-cori disease
IL244353A0 (en) Compounds and use for treating cancer
HK1213817A1 (en) Methods of treating cancer
HK1219653A1 (en) Methods for the treatment of mitochondrial disease
HK1222548A1 (en) Pharmaceutical combinations for the treatment of cancer
HK1219737A1 (en) Novel compounds for the treatment of cancer
HK1219513A1 (en) Methods of treating cancer
HK1223547A1 (en) Methods for the treatment of cancer
GB201403083D0 (en) Treatment of cancer
EP2986294A4 (en) Compounds for treatment of pain
GB201308466D0 (en) Improved process for treatment of minewater
HK1232118A1 (en) Treatment of cancer
GB201307348D0 (en) Garment for therapeutic treatment
HK1224215A1 (en) Use of high dose pridopidine for treating huntingtons disease
PL3016948T3 (en) 2-acylaminothiazoles for the treatment of cancer
EP2986295A4 (en) Compounds for treatment of pain
GB201321628D0 (en) Treatment of disease
GB201322347D0 (en) Treatment of cancer